Navigation Links
Charles D. McCrary Joins Southern Research Institute Board of Directors

BIRMINGHAM, Ala., June 5 /PRNewswire-USNewswire/ -- Officials at Southern Research Institute, a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery, drug and vaccine development, advanced engineering, environmental and energy production, today announced that Charles D. McCrary, President and Chief Executive Officer of Alabama Power Company, has joined the company's Board of Directors.

(Photo: )

"Charles McCrary is not only an outstanding leader of one of the South's preeminent corporations, but a driving force in our community," said Carol Z. Garrison, Ph.D., UAB President and Southern Research Board chair. "He understands and appreciates the importance of research, development and technology transfer to quality of life and economic development, and he champions that vision. He will be a strong addition to this board."

McCrary brings more than 30 years of industry experience to the board, having worked in a variety of roles within the Southern Company family since 1970. Most notably, McCrary has served as President of Southern Company Generation, as well as President of Southern Power Company. He currently serves as President and Chief Executive Officer of the Alabama Power Company.

"Joining the board of the Southern Research Institute is particularly gratifying to me, because one of the founders of Alabama Power, Tom Martin, was a driving force behind its creation," said McCrary. "Although many things have changed since the Institute was chartered in 1941, its mission has remained the same: to develop science and technology in a way that improves the overall quality of life for everyone."

Born and raised in Alabama, McCrary graduated from Auburn University with a B.S. in mechanical engineering. In addition to his work at Alabama Power, he serves on the board of directors for Regions Financial Corporation, Mercedes-Benz U.S. International, Inc., Protective Life Corporation, Business Council of Alabama, Birmingham Museum of Art, and the State of Alabama Archives and History Foundation.

"We are honored to welcome Charles McCrary to our Board of Directors," said John A. "Jack" Secrist, III, Ph.D., president and CEO of Southern Research Institute. "His experience and leadership in the fields of power and energy will be a valuable asset to the board as we look to further expand our research and development capabilities, specifically when it comes to environmental and energy production."

About Southern Research Institute

Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery, vaccine and drug development, advanced engineering, environmental research and energy production. To date, Southern Research has discovered six FDA-approved cancer drugs and discovered six additional drugs that are currently in late stage preclinical and early clinical trials. No other company or institution has brought six of its own cancer drug discoveries to market. For more information, please visit


Rhonda Jung


Southern Research Institute

Nicki Polatin


Schwartz Communications

SOURCE Southern Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
2. Ocular Pharma Company Charlesson Announces $2.35MM in New Funding
3. Charles S. Cohen, Pacific Design Center Augment Their Support for AIDS Walk Los Angeles
4. Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits
5. Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare
6. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
7. Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
8. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
9. Charles Lafitte Foundation Pledges $1 Million to the American Cancer Societys Hope Lodge
10. Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study
11. The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH
Post Your Comments:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... 25, 2015 , ... Many people know of the common symptoms of low ... dry skin. But many people who find their cholesterol levels and weight are creeping ... thyroid, especially if they don’t have any of the other symptoms. , Thyroid hormone ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
Breaking Medicine Technology: